Krystal Biotech (KRYS) Inventory (2023 - 2026)

Krystal Biotech has reported Inventory for 4 years, with the latest figure at $45.6 million in Q2 2026.

• Inventory for Q2 2026 came in at $45.6 million, up 46.76% year-over-year; the trailing twelve-month figure through Jun 2026 was $45.6 million (up 46.76% YoY), and the FY2025 annual result was $40.5 million, up 52.69% from the prior year.
• Inventory improved to $45.6 million in Q2 2026, from $42.6 million in the prior quarter.
• Over five years, Inventory peaked at $45.6 million in Q2 2026 and troughed at $5.3 million in Q3 2023.
• A 4-year average of $25.7 million and a median of $28.2 million in 2024 frame the typical range for Inventory.
• The widest annual swing landed in 2024, when Inventory surged 279.5%; it then surged 42.43% in 2026.
• A 4-year view of Inventory shows it stood at $7.0 million in 2023, then surged by 279.5% to $26.5 million in 2024, then jumped by 52.69% to $40.5 million in 2025, then rose by 12.55% to $45.6 million in 2026.
• Per Business Quant data, the three most recent Inventory figures were $45.6 million in Q2 2026, $42.6 million in Q1 2026, and $40.5 million in Q4 2025.